Study With Atu027 in Patients With Advanced Solid Cancer
NCT00938574
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
34
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumors
Interventions
DRUG:
Atu027
Sponsor
Silence Therapeutics GmbH